ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,958, issued on May 12, was assigned to University-Industry Cooperation Group of Kyung Hee University (Yongin-si, South Korea).
"Virus-like particles containing RSV antigen protein and vaccines using the same" was invented by Fu-Shi Quan (Seoul, South Korea), Ki-Back Chu (Seoul, South Korea) and Su-Hwa Lee (Seoul, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "An RSV virus-like particle which includes a chimeric protein that includes a core consisting of an influenza M1 protein, an RSV-derived preF protein, an RSV-derived G protein or part of G protein displayed on the surface of the core, can exhibit excellent effects in terms of inhibiti...